No Data
No Data
Jefferies Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $28
Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25
Evercore ISI Keeps Their Buy Rating on Altimmune (ALT)
Promising Prospects for Altimmune: Buy Rating Backed by Upcoming Data Readout and Strategic Expansion
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Stifel Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $18
No Data